,i #aaeth ,,congress #ast ,session ,h4 ,r4 #dafi ,,in ,,the ,,house ,,of ,,representatives ,october #ca1 #bjag,mr4 ,marchant 7for himself1 ,mr4 ,smith of ,missouri1 ,mr4 ,simpson1 and ,mr4 ,ferguson7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to remove the enrollment restriction on certain physicians and practitioners prescribing covered outpatient drugs under the ,medicare prescription drug program4 #a4 ,short title ,this ,act may be cited as the ,protecting ,seniors ,access to ,proper ,care ,act of #bjag4 #b4 ,permitting certain non-enrolled physicians or practitioners to prescribe covered outpatient drugs under medicare part d 7a7 ,in general ,section #ahfj;,d-#d of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajc7 is amended by adding at the end the following new subsection3 7m7 ,removal of enrollment restriction 7#a7 ,in general ,nothing in this title or section #fdje7;c7 of the ,patient ,protection and ,affordable ,care ,act shall be construed as authorizing the ,secretary to require1 as a condition of payment by a ,,pdp sponsor for a covered part ,d drug that is prescribed by an applicable physician or practitioner who is authorized under ,state law to prescribe such drug1 that such applicable physician or practitioner be enrolled under section #ahff7;j74 7#b7 ,applicable physician or practitioner defined ,for purposes of paragraph 7#a71 the term applicable physician or practitioner means an eligible professional described in section #ahdh7k77#c77;,b7 7other than a physician described in section #ahfa7r77#a77-- 7,a7 who-- 7i7 is not excluded under this title or title ,,xi2 7ii7 is not barred from participating in the program under this title for a period of time following a revocation under section #dbd4ece7;c7 of title #db1 ,code of ,federal ,regulations 7or any successor regulation72 or 7iii7 meets other criteria similar to clauses 7i7 and 7ii7 that may be specified by the ,secretary2 and 7,b7 who prescribes a low volume 7as determined by the ,secretary7 of such drugs to individuals enrolled in plans under this part4 ,in determining low volume under subparagraph 7,b71 the ,secretary may determine low volume differently based on the specialty of the applicable physician or practitioner4 4 7b7 ,effective date and enforcement delay 7#a7 ,effective date ,the amendment made by subsection 7a7 shall apply to covered part ,d drugs prescribed on or after ,january #a1 #bjai4 7#b7 ,delay in enforcement of enrollment requirement until low volume exemption is implemented ,the ,secretary shall continue not to enforce the enrollment requirement under clauses 7ii7 through 7v7 of section #dbc4abj7;c77#f7 of title #db1 ,code of ,federal ,regulations1 until section #ahfj;,d-#d7m71 as added by subsection 7a71 takes effect4